Opportunity
SAM #75N98027Q00095
NIH seeks 10 Biotech Showcase presentation opportunities and registrations
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
November 19, 2026
Respond By
November 30, 2026
Identifier
75N98027Q00095
NAICS
561920
The National Institutes of Health (NIH) seeks event participation for 10 NIH SEED-selected companies at Biotech Showcase 2027. - Government buyer: NIH, within the Department of Health and Human Services (HHS), through NIH SBIR/STTR and NIH OER SEED; the acquisition offices identified are the Office of Acquisition and Logistics Management (OALM) and NIH Office of Logistics and Acquisition Operations (OLAO). - Event provider: Informa Connect USA LLC. No product manufacturer or OEM is identified. - Requested service: 10 presentation opportunities and event registrations for NIH-selected private companies to showcase their technologies and connect with potential investors and strategic partners. - Event details: Biotech Showcase 2027 will take place at the Hilton San Francisco Union Square in San Francisco, California. The participation supports commercialization of NIH-funded innovations, particularly for smaller, earlier-stage companies. - Line items: One service line item; no part number is provided. No separate product items are listed.
Description
Biotech/Informa Connect USA LLC shall provide presentation opportunities and event registrations for 10 NIH SEED-selected private companies participating in Biotech Showcase, January 11–13, 2027, at the Hilton San Francisco Union Square in San Francisco, California.
This requirement supports NIH OER SEED’s mission to advance research, product development, and commercialization through investment and strategic partnerships. Federal staff and subject matter experts evaluated Biotech Showcase and selected the event based on the alignment of its investor and partnering audience with the needs of smaller, earlier-stage companies. Participation will enable the selected companies to present their technologies, communicate their business needs, and connect with potential investors and strategic partners, supporting the advancement of NIH-funded innovations toward commercialization and potential public benefit.